JoVE Logo

サインイン

7.20 : Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue drug concentration can be mathematically expressed, with Cart and Cven representing the arterial and venous blood drug concentrations, respectively.

Physiological models can be categorized into blood-flow-limited models and diffusion-limited models. In a blood-flow-limited model, drug distribution is primarily regulated by blood flow to the tissue. In contrast, in a diffusion-limited model, the diffusion rate across tissue barriers predominantly controls drug distribution.

The advantages of these models lie in their ability to enhance understanding of complex drug interactions within the body, providing valuable insights for pharmacokinetic studies. Equations such as those expressing the rate of change in tissue drug concentration play a crucial role in quantitatively understanding the dynamics of drug distribution within physiological models. Overall, physiological models in pharmacokinetics serve as powerful tools for understanding the intricate processes involved in drug distribution and elimination within the human body, offering valuable insights for pharmaceutical research and development.

タグ

PharmacokineticsPhysiological ModelsDrug DistributionDrug EliminationDrug UptakePartition CoefficientBlood Flow RateTissue Drug ConcentrationBlood flow limited ModelsDiffusion limited ModelsDrug InteractionsPharmacokinetic StudiesPharmaceutical Research

章から 7:

article

Now Playing

7.20 : Model Approaches for Pharmacokinetic Data: Physiological Models

Pharmacokinetic Models

31 閲覧数

article

7.1 : Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Pharmacokinetic Models

89 閲覧数

article

7.2 : Model Approaches for Pharmacokinetic Data: Compartment Models

Pharmacokinetic Models

77 閲覧数

article

7.3 : One-Compartment Open Model for IV Bolus Administration: General Considerations

Pharmacokinetic Models

161 閲覧数

article

7.4 : One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

Pharmacokinetic Models

207 閲覧数

article

7.5 : One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Pharmacokinetic Models

61 閲覧数

article

7.6 : One-Compartment Model: IV Infusion

Pharmacokinetic Models

161 閲覧数

article

7.7 : One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model

Pharmacokinetic Models

63 閲覧数

article

7.8 : One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model

Pharmacokinetic Models

195 閲覧数

article

7.9 : One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

Pharmacokinetic Models

393 閲覧数

article

7.10 : One-Compartment Open Model: Urinary Excretion Data and Determination of k

Pharmacokinetic Models

139 閲覧数

article

7.11 : Multicompartment Models: Overview

Pharmacokinetic Models

101 閲覧数

article

7.12 : Two-Compartment Open Model: Overview

Pharmacokinetic Models

97 閲覧数

article

7.13 : Two-Compartment Open Model: IV Bolus Administration

Pharmacokinetic Models

400 閲覧数

article

7.14 : Two-Compartment Open Model: IV Infusion

Pharmacokinetic Models

194 閲覧数

See More

JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved